Previous Article | Next Article 
Journal of Virology, September 2000, p. 8502-8512, Vol. 74, No. 18
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Early Alterations of the Receptor-Binding Properties of H1, H2,
and H3 Avian Influenza Virus Hemagglutinins after Their
Introduction into Mammals
Mikhail
Matrosovich,1,2,*
Alexander
Tuzikov,3
Nikolai
Bovin,3
Alexandra
Gambaryan,2
Alexander
Klimov,4
Maria R.
Castrucci,5
Isabella
Donatelli,5 and
Yoshihiro
Kawaoka1,6,7
Department of Virology and Molecular Biology,
St. Jude Children's Research Hospital, Memphis, Tennessee
381051; M. P. Chumakov Institute of
Poliomyelitis and Viral Encephalitides, 142 782 Moscow,2 and Shemyakin Institute of
Bioorganic Chemistry, 117871 Moscow,3
Russia; Influenza Branch, Centers for Disease Control
and Prevention, Atlanta, Georgia 303334;
Department of Virology and WHO National Influenza Centre,
Instituto Superiore di Sanita, Rome 00161, Italy5; Department of Pathology,
University of Tennessee at Memphis, Memphis, Tennessee
381636; and Department of
Pathobiological Sciences, School of Veterinary Medicine, University
of Wisconsin-Madison, Madison, Wisconsin 537067
Received 24 February 2000/Accepted 20 June 2000
 |
ABSTRACT |
Interspecies transmission of influenza A viruses circulating in
wild aquatic birds occasionally results in influenza outbreaks in
mammals, including humans. To identify early changes in the receptor
binding properties of the avian virus hemagglutinin (HA) after
interspecies transmission and to determine the amino acid substitutions
responsible for these alterations, we studied the HAs of the initial
isolates from the human pandemics of 1957 (H2N2) and 1968 (H3N2), the
European swine epizootic of 1979 (H1N1), and the seal epizootic of 1992 (H3N3), all of which were caused by the introduction of avian virus HAs
into these species. The viruses were assayed for their ability to bind
the synthetic sialylglycopolymers 3'SL-PAA and 6'SLN-PAA, which
contained, respectively, 3'-sialyllactose (the receptor determinant
preferentially recognized by avian influenza viruses) and
6'-sialyl(N-acetyllactosamine) (the receptor determinant for human viruses). Avian and seal viruses bound 6'SLN-PAA very weakly,
whereas the earliest available human and swine epidemic viruses bound
this polymer with a higher affinity. For the H2 and H3 strains, a
single mutation, 226Q
L, increased binding to 6'SLN-PAA, while among
H1 swine viruses, the 190E
D and 225G
E mutations in the HA
appeared important for the increased affinity of the viruses for
6'SLN-PAA. Amino acid substitutions at positions 190 and 225 with
respect to the avian virus consensus sequence are also present in H1
human viruses, including those that circulated in 1918, suggesting that
substitutions at these positions are important for the generation of H1
human pandemic strains. These results show that the receptor-binding
specificity of the HA is altered early after the transmission of an
avian virus to humans and pigs and, therefore, may be a prerequisite
for the highly effective replication and spread which characterize
epidemic strains.
 |
INTRODUCTION |
Wild aquatic birds are the natural
reservoirs for influenza A viruses of all known hemagglutinin (HA) and
neuraminidase (NA) subtypes. Such viruses are occasionally transmitted
to other species, including domestic poultry, sea mammals, pigs,
horses, and humans, where they can cause severe outbreaks of influenza
(reviewed in reference 40). For example, the 1957 and 1968 influenza pandemics originated from avian-human reassortant
viruses (H2N2 "Asian" pandemic virus in 1957; H3N2 "Hong
Kong" pandemic virus in 1968). Recent introduction of an
H1N1 avian virus into pigs led to the emergence of a so-called
avian-like swine virus lineage (36). Although progenitors of
H1N1 human viruses and H1N1 "classical" swine viruses have not been
unambiguously identified, they too are thought to have originated from
avian virus precursors.
All influenza A viruses bind to cellular glycoconjugates
containing terminal sialic acid, but the exact molecules
(glycoproteins or glycolipids) that serve as biological
receptors of influenza viruses in birds and other species remain
to be determined. Cellular receptors of influenza viruses appear
to differ among distinct animal species because the binding
specificity of viruses varies considerably depending on the
host animals from which the viruses are isolated. Namely,
human influenza A and B strains and swine influenza viruses
preferentially bind receptors that contain terminal 6'-sialyl(N-acetyllactosamine) residues (6'SLN;
Neu5Ac
2-6Gal
1-4GlcNAc), whereas avian and equine viruses bind
poorly to 6'SLN, preferring instead the terminal
3'-sialylgalactose (Neu5Ac
2-3Gal) moiety (8,
13, 23, 33; see also reference 28 for a
review of earlier data). The molecular mechanisms by which
influenza viruses distinguish between these sialyloligosaccharide
determinants are poorly defined.
A comparison of the amino acid sequences of influenza A viruses from
different hosts revealed six amino acids in the HA receptor-binding site, which are highly conserved among avian viruses (138A, 190E, 194L,
225G, 226Q, and 228G), but bear substitutions in human viruses (23). This finding suggested that mutations at these
positions are required for adaptation of the avian virus HA to human
hosts. However, the role of individual mutations at most of these
positions in the alteration of the HA receptor-binding properties
remains undefined.
Both H2 and H3 human viruses bear the same substitutions, 226Q
L and
228G
S, with respect to the avian consensus sequence (8).
The single mutation 226L
Q in the H3 human virus HA changes its
specificity from preferential Neu5Ac
2-6Gal recognition to preferential Neu5Ac
2-3Gal binding (31, 32). As was shown by site-directed mutagenesis, mutations at position 228 of the human H3
HA affect HA binding to erythrocytes (19, 39); however, the
effects of such mutations on the ability of the HA to recognize the
type of Neu5Ac-Gal linkage were not clearly determined. Interestingly, some H2N2 viruses isolated from humans during the first year of the
1957 pandemic contain 228G (17) as do most avian viruses, whereas some avian H3 viruses contain "human" 228S (2,
16). The receptor-binding properties of such atypical avian and
human viruses have not been characterized. Thus, the contribution of substitutions at position 228 to the adaptation of avian viruses to
human receptors remains unknown.
The currently circulating human H1N1 viruses are thought to have
originated from an avian virus that was transmitted to humans at the
beginning of this century and gave rise to the so-called Spanish
influenza pandemic. At least four mutations in the conserved positions
of the avian receptor-binding site (138, 190, 194, and 225) separate
contemporary H1 human viruses from avian strains (23, 33),
and those in positions 190 and 225 are also present in the recently
sequenced H1N1 human viruses from 1918 (30). Effects of
substitutions at these positions on the HA receptor-binding properties
and their possible contribution to the adaptation of the H1 avian HA to
human hosts are unclear.
Previous studies compared the receptor-binding specificities of
influenza viruses that were already well adapted to their hosts, making
it difficult to define minimal changes in the specificity of the avian
HA required for efficient replication in a new species. Furthermore,
because many mutations have been introduced into the HA of these
viruses since transmission from birds, it has been difficult to
determine the contribution of each mutation to the binding specificity
of this protein. We compare here the receptor-binding properties of the
earliest available influenza viruses isolated during the 1957 and 1968 human pandemics and during swine and seal epizootics with those of
closely related avian viruses of the H1, H2, and H3 subtypes. Two major
questions were addressed: what are the earliest detectable alterations
in the receptor-binding specificity of the avian HA after introduction into a new host, and what are the most critical mutations in the HA
that account for these changes?
 |
MATERIALS AND METHODS |
Viruses.
The viruses used in this study and their
abbreviations are listed in Tables 1 to 3. H2N2 human virus isolates
were from the repository of the Centers for Disease Control and
Prevention, Atlanta, Ga. H1N1 avian-like swine viruses were from the
repository of the Instituto Superiore di Sanita, and seal viruses were
from the repository of the University of Wisconsin-Madison. The R4 reassortant virus, which carries the HA of A/Udorn/307/72 (H3N2) with
the mutation 226L
Q, with all other genes from A/mallard/New York/6750/78 (H2N2), was described previously (24). The R2
reassortant with two mutations (226L
Q and 228S
G) in the HA of
A/Udorn/307/72 was generated by reverse genetics (39). The
other viruses were from the repository of St. Jude Children's Research
Hospital. All viruses were grown in 10- to 11-day-old chicken eggs.
Allantoic fluids were clarified by low-speed centrifugation, and virus
was pelleted by high-speed centrifugation, followed by resuspension in
0.1 M Tris buffer (pH 7.2) containing 50% glycerol, and stored at
20°C.
Sialosides and sialylglycopolymers.
Free
N-acetylneuraminic acid (Neu5Ac),
-methyl glycoside of
N-acetylneuraminic acid (MN; Neu5Ac
2Me), and
3'-sialyllactose (3'SL; Neu5Ac
2-3Gal
1-4Glc) were purchased from
Sigma. 6'-Sialyl(N-acetyllactosamine) (6'SLN) was a gift
from V. E. Piskarev, Nesmeyanov Institute of Organoelement
Compounds, Moscow, Russia. The sialylglycopolymers 3'SL-PAA and
6'SLN-PAA, containing 20 mol% of 3'SL and 6'SLN, respectively, and 5 mol% of biotin attached to a soluble polyacrylamide carrier, were
synthesized as described previously (3). The sialidase
inhibitor zanamivir
(2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid; GG167) was kindly provided by R. Bethell, Glaxo Wellcome R&D.
Assay of virus-binding affinity for sialylglycopolymers.
The
general protocol for this solid-phase receptor-binding assay was
described previously (12). Modifications of the assay for
the present study were limited to the use of synthetic
sialylglycopolymers and of a biotin-streptavidin detection system. In
brief, 50-µl aliquots of bovine fetuin solution in phosphate-buffered
saline (PBS; 5 µg/ml) were incubated in 96-well polyvinyl chloride
microplates (Costar) at 4°C overnight. The plates were washed with
water and air dried. Concentrated virus stocks were diluted with PBS to an HA titer of 20 to 100. Then, 40 µl of virus solution was added to
each well of the fetuin-coated microplates. After incubation at 4°C
overnight, the plates were washed with ice-cold washing buffer (WB;
0.01% Tween 80 in 0.2× PBS). Serial twofold dilutions of
sialylglycopolymers in the reaction buffer (RB; 0.02% Tween 80, 0.02%
bovine serum albumin, 1 µM sialidase inhibitor GG167 in PBS) were
added into the wells (20 µl/well), and the plates were incubated at
4°C for 2 h. After washing, streptavidin-peroxidase solution in
RB (1/2,000) was added at 25 µl/well, and the plates were incubated
at 4°C for 1 h. After washing, the peroxidase activity in the
wells was assayed with o-phenylenediamine substrate
solution. The absorbancies (at 490 nm) were determined with a model
3550 microplate reader (Bio-Rad), transferred to a PC using Microplate Manager 4.0 software (Bio-Rad), and processed with Microsoft Excel software. The data were converted to Scatchard plots
(A490/C versus A490, where C is the concentration of
the sialylglycopolymer and A490 is the
absorbency in the corresponding well; see Fig. 1). The apparent
association constants of virus complexes with sialylglycopolymers (Kass) were determined from the slopes of these
plots and are expressed in micromolar amounts of Neu5Ac (with respect
to concentration of sialic acid residues present in the solution).
Because the assay includes extensive washing steps and is based on a
complex multivalent binding of sialylglycopolymers to a virus with
numerous HAs, these constants are not true equilibrium association
constants. However, they provided a reliable and convenient measure of
the relative affinity of viruses for the sialylglycopolymers. Thus, although the absolute values of the apparent association constants determined on different days varied up to fourfold, the relative affinities of the viruses were highly reproducible. The data presented in the tables are average values of two to three independent
experiments performed on different days.
Assay of virus binding of sialic acid and sialosides.
The
apparent association constants of the influenza virus complexes with
low-molecular-mass receptor analogs were determined in a fetuin-binding
inhibition assay, as previously described (12, 22). This
assay is based on the competition between the receptor analog under
study and a standard preparation of peroxidase-labeled fetuin for the
binding sites on a solid-phase immobilized virus. The competitive
reaction was performed for 1 h at 2 to 4°C in the presence of 1 µM GG167 to block the activity of viral neuraminidase.
Analysis of HA amino acid sequences.
The HA amino acid
sequences were obtained from GenBank. The sequences were analyzed with
the use of GeneDoc 2.3 software (25; Karl B. Nicholas and Hugh B. Nicholas, Jr. [GeneDoc,
http://www.cris.com/~Ketchup/genedoc.shtml]). Only partial sequences
that covered the region of the receptor-binding site of the HA (amino
acids 130 to 230 of HA1) were analyzed. This region was arbitrarily
defined by a sphere with a 15-Å radius around the glycosidic oxygen
atom of the bound sialic acid in the X31 HA complex with
3'-sialyllactose (1HGG structure; Protein DataBank). The H3 numbering
system, in accord with the alignment of Nobusawa et al.
(26), is used throughout this study.
Phylogenetic relationships among the H1N1 viruses from different hosts
were estimated with the PHYLIP 3.572 software package (11; J. Felsenstein, Phylogeny Inference Package,
version 3.5c [1993], Department of Genetics, University of
Washington, Seattle [http://evolution.genetics.washington.edu/phylip.html]). The tree was
obtained for the amino acid sequences of the whole HA1 by using a
neighbor-joining algorithm and the Dayhoff PAM matrix; H2 HA was used
as an outgroup. The TREEVIEW 1.5.2 program (27) was used to
draw the tree.
The positions of distinct amino acid residues with respect to the virus
receptor-binding site and bound sialyloligosaccharides
were analyzed
with the RasMol 2.6 (
34) and WebLab ViewerPro
3.10 (Molecular Simulations, Inc., San Diego, Calif.) computer
programs. The
crystallographic structure of the X31 HA complex
with pentasaccharide
LSTc (
10) was kindly provided by M. B.
Eisen.
 |
RESULTS |
Assay of virus receptor-binding specificity.
To
determine the receptor-binding specificity of influenza viruses
in previous studies, we used two synthetic sialylglycopolymers, 3'SL-PAA and 6'SLN-PAA (carrying the Neu5Ac
2-3Gal and
Neu5Ac
2-6Gal moieties, respectively), and a competitive
binding assay (13). In the present study, we developed a
direct binding assay by using biotin-labeled polymers. The viruses were
immobilized in the wells of microtiter plates and were then incubated
with variable concentrations of biotinylated sialylglycopolymers. The
amount of bound polymer was determined with a streptavidin-peroxidase
detection system. This assay is technically simpler than competitive
assays, and the Scatchard transformation of the binding data
enables easy determination of apparent association constants from
the slopes of binding plots. Figure
1 shows examples of primary binding data and corresponding Scatchard plots. The 3'SL-containing polymer bound
strongly to the duck virus duck/Hokkaido/33/80 (H3N8) and bound
substantially more weakly to the human strain Los Angeles/2/87 (H3N2).
By contrast, 6'SLN-PAA bound much better to the human strain than it
did to the avian strain. This binding pattern agrees with results
obtained for nonbiotinylated polymers in a competitive binding assay
(13).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Binding of sialylglycopolymers 3'SL-PAA (solid lines)
and 6'SLN-PAA (dotted lines) by H3 subtype influenza virus strains
A/duck/Hokkaido/33/80 and A/Los Angeles/2/87. The binding assay is
described in Materials and Methods. The upper panels represent the
primary data (dependence of absorbancy in the wells,
A490, versus concentration of the polymer); the
lower panels show the corresponding Scatchard plots.
|
|
Alterations of the avian H3 HA at the beginning of the 1968 Hong
Kong pandemic.
The reassortant virus possessing an avian H3 HA and
all other genes from a previously circulating human virus caused the
1968 pandemic. A few mutations in the HA, including those at positions 144, 193, 226, and 228, were found to separate the earliest human isolate Aichi/2/68 from its putative avian virus precursor
(2) (see Fig. 3 for the location of these mutations on the
HA molecule). To determine the contribution of these mutations to the
receptor-binding properties, we compared
sialylglycopolymer-binding activities of viruses described by Bean et
al. (2). All H3 avian viruses exhibited the same
binding specificity, that is, they bound 3'SL-PAA more than an order of
magnitude better than they did 6'SLN-PAA (Table
1). Three of the avian H3 viruses tested
(duck/Hokkaido/8/80, mallard/NY/6874/78, and
duck/Hokkaido/7/82) differed from other avian viruses by having
arginine or serine instead of glycine in HA position 228 (Fig.
2, H3). The first two strains and
duck/Ukraine/63 virus reproducibly showed two- to threefold lower
affinities for 3'SL-PAA compared to duck/Hokkaido/7/82 and other H3
avian strains. Although duck/Ukraine/63 bears "avian" 226Q
and 228G (amino acids conserved among the majority of avian HAs),
it also has a nonconservative substitution, 227S
P, in the HA that
can affect the structure of the region surrounding this residue.
Because dk/Hokkaido/7/82 was reported to contain 228S (16)
but did not differ in our experiments from H3 viruses with 228G, the HA
sequence of the preparation of the virus we used in the binding studies
was determined. The HA was found to contain glycine at position 228. These findings indicated that the presence of an "atypical" amino
acid at position 228 (and 227) correlated with a lower affinity for
3'SL-PAA. Mutations 228G
R and 227S
P did not substantially
increase the affinity for 6'SLN-PAA.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 2.
Partial HA amino acid sequences (HA1 positions 130 to
230) of influenza viruses that were tested for their binding to
sialylglycopolymers. Full names of the virus strains are listed in
Tables 1 to 3. Differences with respect to the top sequence are shown.
The H3 numbering system is used; the position in the H1 HA that is
absent from the H3 HA is indicated by an underscore. The RBS line shows
the position of the amino acid with respect to the HA receptor-binding
site. The "R" designates that the amino acid residue contacts
either sialic acid or penultimate galactose in the X31 virus HA complex
with 3'-sialyllactose (1HGG structure; Brookhaven Protein Database).
The star indicates that an amino acid is within 15 Å of the C2 carbon
atom of the sialic acid in the 1HGG structure. The figure was generated
with GeneDoc 2.3 software (25).
|
|
All human H3 isolates, including the earliest, Aichi/2/68, bound to
6'SLN-PAA with a higher affinity and to 3'SL-PAA with
a lower affinity
than did all of the avian viruses tested. The
Aichi/2/68 HA bears
substitutions 144G, 182I, 193S, 226L, and
228S with respect to the
avian HA consensus sequence (Fig.
2).
The 182V

I mutation of
Aichi/2/68 is unique and is absent in other
human virus strains; hence,
it is unlikely to be critical for
the "human" receptor-binding
phenotype. Because 144G is present
in the HA of the avian virus
mallard/NY/6874/78 that does not
bind to 6'SLN-PAA any better than
other avian viruses, it is probably
not essential for the increased
affinity of human viruses for
6'SLN-PAA. The duck/Memphis/74 strain
reproducibly bound to 6'SLN-PAA
more weakly than any other avian virus.
This feature correlates
with the presence of 193D in this HA
receptor-binding site (RBS),
whereas other avian viruses bear 193N, and
the early human strains
bear 193S. Residue 193 is relatively far from
the region of the
RBS, which accommodates the Neu5Ac

2-6Gal moiety
(
10), but it
can potentially interact with more distant
saccharide rings of
the Neu5Ac

2-6Gal-terminated receptors and with
the polymeric
part of 6'SLN-PAA (Fig.
3).
Although these findings suggest that
mutations at position 193 can
modulate the recognition of 6'SLN-containing
receptors, substitutions
in positions 226 and 228 appear to be
primarily responsible for the
differences in the receptor specificity
between avian viruses and
Aichi/2/68.

View larger version (144K):
[in this window]
[in a new window]
|
FIG. 3.
Positions of amino acids in the HA receptor-binding site
that differ between early epidemic human and swine viruses and their
closely related avian counterparts (stereo view). The figure is based
on the crystallographic model of the X31 HA complex with the
Neu5Ac 2-6Gal-containing receptor analog LSTc
(Neu5Ac 2-6Gal 1-4GlcNAc 1-3Gal 1-4Glc) (10). The
solvent-accessible molecular surface of the protein is shown. The
sialic acid residue and penultimate galactose ring of LSTc are
displayed as thick stick bonds; the rest of the molecule is shown as a
thin white line. The gray transparent sphere (C6) in close
proximity to amino acid 226 represents the van der Waals surface of the
C6'-carbon atom of Gal. The figure was generated with WebLab ViewerPro
3.10 (Molecular Simulations, Inc., San Diego, Calif.).
|
|
To further evaluate the effects of mutations 226Q

L and 228G

S on
changes of the receptor-binding properties of avian HA,
we analyzed
laboratory variants of the human virus Udorn/307/72,
which possessed
distinct amino acids at these positions (Table
1). The R2 variant, for
example, bears "avian" amino acids at
both positions and is
indistinguishable from the natural avian
H3 viruses with respect to its
binding to sialylglycopolymers.
Thus, in the presence of 226Q/228G,
other amino acids that differ
from avian viruses (i.e., at positions
144, 155, 188, and 193)
do not appear to substantially affect the avian
virus-like receptor-binding
specificity of the R2 virus. The R4 variant
has a single mutation,
228G

S, with respect to R2. This substitution
has no effect on
the affinity of the HA for 6'SLN-PAA but reduces its
affinity
for 3'SL-PAA, similar to the effect of substitution 228G

R
in
the avian viruses described above. By contrast, the substitution
226Q

L (compare the R4 variant with its parent, Udorn/72) markedly
changes the receptor-binding properties of the virus by both
substantially
increasing its affinity for 6'SLN-PAA and decreasing its
affinity
for 3'SL-PAA. These data show that the 226Q

L mutation
primarily
determines the change in recognition of the Neu5Ac-Gal
linkage
during interspecies transfer, whereas substitutions of glycine
at position 228 of the avian HA have only limited effect on the
Neu5Ac-Gal linkage
specificity.
Alterations of the avian H2 HA at the beginning of the Asian
pandemic.
The "Asian" pandemic of 1957 was caused by a
reassortant virus that contained the genes of the surface glycoproteins
and the PB1 protein from an H2N2 avian strain and the remainder from a human virus. We analyzed the receptor-binding properties (Table 2) and amino acid sequences (Fig. 2, H2)
of the panel of H2 avian viruses (35) and the earliest known
H2 human strains (17).
All H2 avian viruses contained 226Q and 228G and bound
strongly to 3'SL-PAA and weakly to 6'SLN-PAA. Among the H2N2
viruses
isolated from humans in the first year of the pandemic, three
strains (El Salvador/57, Leningrad/57, and RI/5

/57) carried the
amino acids typical for avian viruses, 226Q and 228G, and displayed
the
avian virus-like receptor-binding phenotype. In contrast to
these
strains, Davis/57 contains only one amino acid substitution
in the
region of the receptor-binding site, 226Q

L, whereas Albany/57
contains two substitutions, 226Q

L and 186N

I. Both of these
variants
with 226L displayed a dramatic shift in receptor-binding
activity,
with their affinity for 6'SLN-PAA increasing ca. 10-fold and
that
for 3'SL-PAA decreasing >10-fold. Thus, these two strains are
similar to the earliest human H3 pandemic strain, Aichi/2/68,
with
respect to their affinity for sialylglycopolymers. The RI/5+/57
strain
and other H2 human viruses isolated in later years displayed
a further
twofold increase in affinity for 6'SLN-PAA; this feature
correlates
with the presence of serine at position 228 of the
HA. Among the human
H2 viruses, the Ann Arbor/6/60 strain showed
the most unusual
receptor-binding properties. Despite the presence
of 226L/228S, the
receptor-binding specificity of this strain
is closer to that of
the avian viruses. Three substitutions in
the RBS region (137R

Q,
158G

E, and 186N

I; Fig.
2, H2), which
separate this strain from
the human consensus sequence, could
be responsible for the altered
binding specificity. Mutations
in HA positions 137 and 186 were
previously found to be involved
in the adaptation of human H3N2 virus
to growth in the presence
of animal sera, the receptor specificity of
the serum-resistant
variants being similar to that of Ann Arbor/60
(
20).
Receptor-binding specificity of H3 viruses from seals.
In
1991, H3N3 avian virus-like viruses were isolated from lung tissues of
seals that died of pneumonia along the Cape Cod peninsula of
Massachusetts (5). We examined four seal viruses isolated at
different times during the outbreak (Table 1); the HA sequences of two
had been determined earlier (Fig. 2, H3). Three of the four isolates
displayed a typical avian virus-like pattern of binding to
sialylglycopolymers, that is, an affinity for 3'SL-PAA of about 50 µM
1 and an affinity for 6'SLN-PAA of about 1 µM
1. This finding suggests that an avian influenza
virus can infect seals without substantial changes in its
receptor-binding specificity. By comparison with three other H3 seal
viruses, seal/MA/3984/92 showed a lower binding affinity for 3'SL-PAA
with no increase in binding to 6'SLN-PAA. The reasons for this
discrepancy are not presently clear. Two amino acid substitutions in
the upper portion of the HA globular head, 138A
S and 220R
S,
separate this strain from the seal/MA/3911/92 virus. Both substitutions
involve amino acid residues that are conserved among influenza virus
HAs of all antigenic subtypes (23, 26). Position 220 is
located on the boundary between the HA monomers relatively distant from the RBS. Amino acid 138 resides in the receptor-binding pocket (Fig. 3)
and is much more likely to be responsible for the decreased binding to
3'SL-PAA.
Alterations of avian H1N1 viruses during their replication in
pigs.
In 1979, an avian virus-like virus was isolated from pigs
(36). This virus continues to circulate in European pigs
(4, 18) and provides a rare opportunity for investigation of
the receptor-binding specificity changes during adaptation of an avian virus to a new host. Besides so-called avian-like swine viruses, "classical" H1N1 swine influenza virus strains were included in this study to represent the receptor-binding properties of viruses that
have circulated in pigs for about 80 years and are highly adapted to
this host (Fig. 4 shows phylogenetic
relationships among H1 avian, swine, and human viruses).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Phylogenetic tree for H1 subtype influenza viruses from
different hosts, as determined based on the amino acid sequences of the
HA1. The tree was constructed as described in Materials and Methods
using the HA sequences of viruses listed in Fig. 2 and the following
sequences of classical swine and human viruses from GenBank:
sw/Iowa/15/30, WSN/33, PR/8/34 (Cambridge strain), FM/1/47, USSR/90/77,
Taiwan/1/86, and Finland/168/91. The figure was generated with the
TREEVIEW 1.5.2 program (27).
|
|
We found that the receptor-binding characteristics of H1N1 avian
strains are similar to those of H2 and H3 avian viruses (Table
3). By contrast, the early avian-like
swine isolates swine/Arnsberg/79
and swine/Netherlands/80 showed a
substantial increase in affinity
for 6'SLN-PAA. Notably, these swine
viruses bound 6'SLN-PAA with
the same affinity as do the early human
pandemic strains Albany/57
(H2N2), Davis/57 (H2N2), and Aichi/68
(H3N2). Unlike H2 and H3
human viruses, the early avian-like
swine viruses retained the
ability of their avian predecessors to bind
3'SL-PAA. However,
the affinity for 3'SL-PAA shown by swine isolates
from subsequent
years was gradually reduced, reflecting continued
evolution of
the virus in swine. The three more recent avian-like swine
viruses
isolated in 1987, 1991, and 1992 displayed binding affinities
that were similar to those of classical swine viruses.
Four amino acid substitutions affecting the avian virus consensus
sequence are present in the region of the receptor-binding
site of the
early avian-like swine viruses swine/Arnsberg/79 and
swine/Netherlands/80 (positions 155, 159, 190, and 225; see Fig.
2, H1,
and Fig.
3). One or more of these substitutions should
be thus
responsible for the increase in the affinity of avian
H1 HA for the
6'SLN-PAA-containing glycopolymer. We therefore
compared amino acid
residues at these positions among the H1 HAs
of classical swine and
human viruses (Table
4). These positions
were conserved in all 13 H1 avian HAs analyzed. Although classical
swine viruses and avian-like swine viruses belong to distinct
phylogenetic lineages (Fig.
3), most strains of both lineages
carry the
same substitutions, 155T

V, 159T

N, and 190E

D, suggesting
that
these changes are essential for adaptation of the avian HA
to swine
hosts. The mutation 225G

E is present in the HA of two
early
avian-like swine viruses but is absent in later isolates
(Fig.
2) and
in the classical swine strains. Thus, although this
substitution could
be involved in the early stages of adaptation
of the avian H1 HA to
swine, it was not preserved during subsequent
replication of the virus
in this host.
Among the human viruses, no changes in the avian sequence were detected
at position 155, whereas a substitution at position
159 (T

G)
differed from that in swine viruses (T

N or T

S). Because,
similar
to swine viruses, H1N1 human viruses display a high binding
affinity
for 6'SLN-PAA (
13), one can conclude that amino acids
at
these two positions are not of primary importance for recognition
of
the 6'SLN determinants. What, then, can be the role of these
substitutions for HA adaptation to swine? The side chain of the
amino
acid at position 155 participates in the formation of the
pocket that
accommodates the acyl substituent at 5-N of Neu5Ac
(see Fig.
3). Thus,
we hypothesize that the substitution 155T

I/V
in the swine virus HA
increases the affinity of the virus for
5
N-glycolyl analog
of the sialic acid that is abundant in pigs
but absent in birds and
humans (see reference
38 and references
therein).
Amino acid 159 is at the tip of the HA (Fig.
3) and
therefore could
potentially affect interactions of viruses with
the distant parts of
the sialyloligosaccharides or with protein
parts of the
receptors.
Most human viruses bear the same substitution as swine viruses at
position 190 (E

D) and carry a similar substitution at position
225 (G

D). In fact, every swine and human H1 HA analyzed in this
study
differed from the avian consensus at least in one of these
positions
(Table
4). Thus, mutations at positions 190 and 225
correlate most
closely with the ability of the virus to bind 6'SLN
and appear then to
be primarily involved in the adaptation of
the H1 avian virus HA to
swine and
humans.
Probing of the HA receptor-binding specificity with monovalent
sialosides.
To gain insight into the molecular mechanisms by which
mutations in key HA positions alter the receptor-binding specificity of
the avian virus HA during adaptation to other hosts, we compared the
binding affinities of the test viruses for low-molecular-mass receptor
analogs: free N-acetylneuraminic acid, methyl sialoside (MN), 3'SL, and 6'SLN. The absolute values of association constants and
the relative affinities with respect to the affinity for the
-anomer
of sialic acid (Krel) are presented in Table
5.
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Binding of monovalent receptor analogs, free -anomer
of Neu5Ac, -methylglycoside of Neu5Ac (MN), 3'SL, and 6'SLN by
influenza virusesa
|
|
Comparison of binding patterns indicated three distinct groups of
viruses. The first included authentic avian viruses
(mallard/Tennessee/85
and duck/Hokkaido/82), human strains with the
"avian" consensus
sequence 226Q/228G (R2 and Leningrad/57), and R4.
These viruses
bound 3'SL ca. 10-fold more avidly than free sialic acid
(
Krel from 8.3 to 20), indicating significant
energetically favorable
interactions between the avian virus HA and the
3-linked lactose
moiety of 3'SL. They also showed weak relative binding
to 6'SLN
and methyl sialoside by comparison to free Neu5Ac. Thus, the
asialic
parts of 6'SLN and MN do not appear to fit into the
receptor-binding
site of the HA without significant energy losses.
Although R4
differed from other strains in this group by virtue of a
228G

S
substitution, it displayed a binding pattern typical of other
avian viruses. This finding supports the notion that a single
228G

S
mutation in the avian HA does not markedly alter its receptor-binding
characteristics as detected in this assay (see above and Tables
1 and
2).
The viruses of the second group (Albany/57, RI/5+/57,
Aichi/68, and Udorn/72) are human isolates of the H2 and H3
subtype
that share a common substitution, 226Q

L from the avian
consensus
sequence. Among them, Albany/57 carries the "avian" 228G
but displays
a binding pattern similar to that of other viruses from
this group.
Thus, 226L must be primarily responsible for their
receptor-binding
characteristics, regardless of the amino acid at
position 228.
Comparison between viruses with 226L and those of the
first group
(226Q) revealed several changes in receptor-binding
properties.
First, the substitution Q

L increased the affinity for
6'SLN and
MN, an effect that correlated with an increase in
Krel. Thus,
the improved binding of these
viruses to 6'SLN and MN appears
to stem from a better fit of their
asialic portions,
N-acetyllactosamine
and methyl moieties,
due to the 226Q

L mutation. These two moieties
share one structural
feature, the hydrocarbon group, which participates
in the formation of
the glycosidic bond with sialic acid (6'-CH
2 group of Gal
in 6'SLN and 2-methyl group of MN). According to
a model of the human
virus HA complexed with Neu5Ac

2-6Gal-containing
sialyloligosaccharide LSTc (Fig.
3), this hydrocarbon group is
positioned in immediate proximity to the amino acid at position
226. Hence, there may be direct steric interference in the avian
HA between
226Q and the 6-hydrocarbon group of galactose, and
a mutation from
glutamine to leucine may create more room to accommodate
this group.
Another characteristic effect of the 226Q

L mutation
is an
appreciable decrease in affinity for 3'SL, rendering it
comparable to
the affinity for free
N-acetylneuraminic acid
(
Krel = 0.4 to 0.9). Thus, the leucine at
position 226 of the HA appears
to abrogate favorable interactions
between the 3-linked lactose
and the protein that are typical for the
avian virus
HA.
Swine viruses belong to a third receptor-binding group, which resembles
human H2 and H3 viruses with their higher affinity
for 6'SLN compared
to that of avian virus strains. However, the
detailed molecular
mechanism responsible for the increased affinity
for the 6'SLN moiety
appears to differ between the swine and human
viruses. That is, H1
swine strains show no enhancement of their
relative affinities for
6'SLN and MN but do have a substantially
higher affinity for free
Neu5Ac compared to the avian viruses.
We conclude, therefore, that the
HAs of swine viruses have a higher
absolute affinity for 6'SLN and MN
because the affinity of the
HA for the sialic acid moiety of these
analogs is increased. Another
difference between the human and swine
viruses is a higher absolute
and relative affinity of swine viruses for
3'SL (and, as a consequence,
for 3'SL-PAA; see Table
3). This feature
indicates that amino
acid substitutions in the receptor-binding pocket
of H1 swine
viruses (most likely, those in positions 190 and 225)
decrease
HA interactions with the 3-linked galactose moiety of 3'SL
less
markedly than does the 226Q

L mutation in the human H2 and H3
HAs.
To find a molecular basis for the decreased affinity of seal/MA/3984/92
isolate for 3'SL-PAA, we analyzed this virus and the
seal/MA/3911/92
strain for their binding of Neu5Ac and 3'SL. The
results presented in
Table
5 indicate that the former virus has
a markedly decreased
affinity for 3'SL because it does not bind
to the asialic portion of
the 3'SL (
Krel[3'SL] = 0.9). Thus, the
138A

S substitution in the HA of seal/3984/92 abolishes the fit
of
the 3-linked Gal moiety to the avian receptor-binding
site.
 |
DISCUSSION |
The intent of this study was to gain insight into the initial
events allowing transmission of avian virus HA to humans and other
species by analyzing alterations of viral receptor-binding properties
early after introduction of virus from birds to humans, pigs, or seals.
We found that the majority of avian viruses, irrespective of their HA
subtype, displayed very similar patterns of binding to 3'SL-PAA and
6'SLN-PAA polymers, with affinities ranging from 50 to 100 µM
1 (3'SL-PAA) and 1 to 2 µM
1
(6'SLN-PAA). These data indicate that the receptor-binding properties of viruses of wild aquatic birds are relatively conserved. The earliest
available isolates of pandemic human H2 and H3 viruses and of epizootic
avian-like swine H1 viruses bound 6'SLN-PAA with at least a
fourfold-higher affinity than did the avian viruses. It can be
concluded, therefore, that the ability to recognize 6'SLN was acquired
relatively early after the introduction of an avian virus into humans
and pigs, at least by the time influenza epidemics became apparent and
viral isolates were obtained. The affinity of human and pig viruses for
6'SLN-PAA somewhat increased during consecutive years of epidemics,
suggesting continued refinement of receptor-binding properties in these
new hosts.
Our results confirm previous conclusions of Connor et al.
(8) that the receptor-binding properties of H2 human virus
strains with 226Q/228G are similar to those of avian H2 viruses. One of these strains (A/RI/5
/57) is a laboratory mutant selected by passage
of parental human virus (226L/228S) in the presence of horse serum
(6). The exact passage history of the two other strains is
unknown. However, because any virus from 1957 must have been isolated
and undergone multiple passages in eggs, these strains, similar to
RI5
/57, may be receptor-binding mutants derived in the laboratory.
Indeed, a shift toward an avian virus-like receptor specificity has
been well documented upon passage in eggs of human influenza A and B
viruses (13, 15, 30a) and of H2 isolates from 1957 in
particular (see reference 8 and references therein).
For these reasons, there is no clear evidence that H2N2 viruses with
avian virus-like receptor specificity replicated in humans. By
contrast, "human virus-like" H2N2 isolates certainly circulated
among humans during the first year of the 1957 pandemic, because egg
adaptation never favors selection of mutants with human virus-like
specificity (15, 30a).
Besides their increased affinity for 6'SLN, another characteristic of
the earliest available H2 and H3 subtype human viral HAs was their
substantially decreased affinity for 3'SL-PAA compared to that of avian
viruses. This feature may indicate that there is negative selective
pressure in humans against viruses with this specificity. The mechanism
for such pressure could be neutralization of the virus by human
respiratory mucins, which are known to carry predominantly
Neu5Ac
2-3Gal moieties (references 1 and
9 and references therein). Alternatively, a
decreased affinity for Neu5Ac
2-3Gal could merely reflect effects of
HA mutations that became fixed under selective pressure for stronger
binding to 6'SLN.
In contrast to human and swine viruses, there were no changes in
the receptor-binding specificities among three of the four viral
isolates from seals. Thus, either the selective pressure against
viruses with avian receptor specificity is low (or absent) in these
species or else the animals were only recently infected with avian
viruses so that there was not enough time for the selection to occur.
Previously, we identified six key amino acid positions in the HA
receptor-binding site that are highly conserved in the avian influenza
viruses but can change during adaptation of the avian HA to humans
after interspecies transfer (23). In this study, we further
defined roles of five of these mutations in the changes of the
receptor-binding properties of the HA. First of all, we found that a
single mutation at position 138, 190, 225, 226, or 228 of the avian HA
decreases the affinity of the virus for receptor analogs 3'SL and
3'SL-PAA and, therefore, most likely, for cellular receptors on the
target cells of avian intestinal epithelia. This finding can explain
previous reports concerning the inability of H3 viruses with a single
228G
S substitution in the HA to replicate in the intestinal tract of
ducks (24, 39). Binding data indicate that the affinity for
Neu5Ac
2-3Gal determinants decreases because mutations at these
positions lower (positions 190, 225, and 228) or completely abrogate
(positions 138 and 226) the favorable interactions of viruses with the
3-linked galactose moiety of the receptor analog (see Table 5, relative
binding to 3'SL). These data support our hypothesis about a tight
fit of the Gal moiety of the Neu5Ac
2-3Gal determinant to the avian
receptor-binding site and its destruction by these mutations
(23, 39).
In apparent conflict with this interpretation is the presence of
mutations at position 228 and the lowered affinity for 3'SL-PAA of some
H3 viral isolates from wild ducks (2, 16) (see Fig. 2, H3).
It cannot be excluded, however, that these viruses, as well as
seal/MA/3984/92 (138S), are laboratory variants. As shown recently for
the receptor-binding variants of swine influenza virus A/NJ/11/76, the
virus with the lower affinity for cellular receptors can readily
outgrow the high-affinity variant in laboratory passages because of
more-rapid release from cells and, consequently, more-rapid spread
(14). In natural infection, by contrast, a higher affinity
may be required for efficient transmission of the virus from one
infected host to another (a task performed in laboratory passages by
the researcher).
The available data strongly suggest that the avian HA in humans and
swine is subjected to selective pressure toward mutants with increased
affinity for the 6'SLN determinant and decreased affinity for
Neu5Ac
2-3Gal. Our data show that the substitution 226Q
L in the H2
and H3 HA is most critical for this change, whereas an additional
mutation, 228G
S, makes only a marginal contribution. It is tempting
to speculate in this view that the human viral isolates Davis/57 and
Chile/57 with 226L and 228G (17) represent the earliest
steps of adaptation of the avian H2 HA to humans.
In the case of the H1 HA, we could not compare receptor-binding
properties of early human and avian viruses because such isolates are
not available. However, a good correlation between mutations in the
avian H1 HA in swine and substitutions in the same positions in human
viruses suggests either similar molecular mechanisms of H1 HA
adaptation to these hosts or origination of H1 human viruses and
classical swine viruses from a common precursor virus that carried
mutations in the RBS. The binding data (Table 3) suggest that mutations
190E
D and/or 225G
E/D are most critical for enhancement of the
affinity of the avian H1 HA affinity for 6'SLN and decrease in binding
to Neu5Ac
2-3Gal. This conclusion is supported by the fact that
substitutions in these two positions (often with reversion to the avian
consensus sequence) are commonly observed during the egg adaptation of
contemporary human H1N1 influenza viruses and have the most profound
effect on the virus recognition of the type of Neu5Ac-Gal linkage
(15).
Substitutions at positions 190, 225, and 226 and some others in the
receptor-binding site of avian virus-like viruses isolated from other
species could serve as markers of the virus host and potential to cause
epidemics. For example, the amino acid sequences of three 1918 H1N1
virus strains from the "Spanish" influenza pandemic have been
reported recently (30). These sequences were derived
directly from viral RNA present in tissues of infected humans and would
be therefore free from artifacts of laboratory adaptation. All
three variants bear 190D, and two of them additionally carry
225D, suggesting that 1918 pandemic viruses had a swine virus-like
receptor-binding specificity recognizing both 6'SLN- and
Neu5Ac
2-3Gal-containing receptors. However, these viruses have 155S,
which is typical of avian and human viruses but not of swine viruses.
The latter notion seems to be more consistent with the theory that the
1918 influenza virus spread from humans to swine (30) rather
than in the opposite direction. Another example is the H5N1 viruses
isolated from humans during the 1997 outbreak in Hong Kong that carry
no substitutions in positions 190, 225, and 226 (7, 37) and
display avian virus-like receptor-binding specificity (21).
These properties are consistent with the direct introduction of these
viruses from chickens to humans and with the fact that viruses were not
transmitted from human to human.
In summary, our data suggest that a shift of the receptor-binding
specificity of the avian virus HA from Neu5Ac
2-3Gal recognition to
Neu5Ac
2-6Gal recognition is a prerequisite for the generation of
human pandemic viruses. The results also indicate that one or two amino
acid mutations in the avian virus HA are sufficient for this shift;
hence, a limited number of replications of an avian virus in humans
appears to be sufficient for such changes.
 |
ACKNOWLEDGMENTS |
We thank Peng Gao for sequencing the HA1 gene of dk/Hokkaido/7/82
virus, V. E. Piskarev for the generous gift of 6'SLN, and M. B. Eisen for crystallographic structures of influenza virus HA
complexes with sialyloligosaccharides. We are grateful to R. Bethell of
GlaxoWellcome R&D for providing the NA inhibitor zanamivir (GG167).
We also thank Krisna Wells and Martha McGregor for technical assistance
and J. Gilbert for editing the manuscript.
This work was supported by Public Health Service research grants from
the National Institute of Allergy and Infectious Diseases, by Cancer
Center Support (CORE) grant CA-21765, and by the American Lebanese
Syrian Associated Charities. Mikhail Matrosovich was supported by a
Karnofsky fellowship from St. Jude Children's Research Hospital.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Virology and Molecular Biology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105-2794. Phone: (901) 495-3412. Fax: (901) 523-2622. E-mail:
Mikhail.Matrosovich{at}stjude.org.
 |
REFERENCES |
| 1.
|
Baum, L. G., and J. C. Paulson.
1990.
Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity.
Acta Histochem. Suppl. Band
XL:35-38.
|
| 2.
|
Bean, W. J.,
M. Schell,
J. Katz,
Y. Kawaoka,
C. Naeve,
O. Gorman, and R. G. Webster.
1992.
Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.
J. Virol.
66:1129-1138[Abstract/Free Full Text].
|
| 3.
|
Bovin, N. V.,
E. Y. Korchagina,
T. V. Zemlyanukhina,
N. E. Byramova,
O. E. Galanina,
A. E. Zemlyakov,
A. E. Ivanov,
V. P. Zubov, and L. V. Mochalova.
1993.
Synthesis of polymeric neoglycoconjugates based on N-substituted polyacrylamides.
Glycoconj. J.
10:142-151[CrossRef][Medline].
|
| 4.
|
Brown, I. H.,
S. Ludwig,
C. W. Olsen,
C. Hannoun,
C. Scholtissek,
V. S. Hinshaw,
P. A. Harris,
J. W. McCauley,
I. Strong, and D. J. Alexander.
1997.
Antigenic and genetic analyses of H1N1 influenza A viruses from European pigs.
J. Gen. Virol.
78:553-562[Abstract].
|
| 5.
|
Callan, R. J.,
G. Early,
H. Kida, and V. S. Hinshaw.
1995.
The appearance of H3 influenza viruses in seals.
J. Gen. Virol.
76:199-203[Abstract/Free Full Text].
|
| 6.
|
Choppin, P. W., and I. Tamm.
1959.
Two kinds of particles with contrasting properties in influenza A virus strains from the 1957 pandemic.
Virology
8:539-542[Medline].
|
| 7.
|
Claas, E. C. J.,
A. D. M. E. Osterhaus,
R. Vanbeek,
J. C. Dejong,
G. F. Rimmelzwaan,
D. A. Senne,
S. Krauss,
K. F. Shortridge, and R. G. Webster.
1998.
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.
Lancet
351:472-477[CrossRef][Medline].
|
| 8.
|
Connor, R. J.,
Y. Kawaoka,
R. G. Webster, and J. C. Paulson.
1994.
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates.
Virology
205:17-23[CrossRef][Medline].
|
| 9.
|
Couceiro, J. N.,
J. C. Paulson, and L. G. Baum.
1993.
Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity.
Virus Res.
29:155-165[CrossRef][Medline].
|
| 10.
|
Eisen, M. B.,
S. Sabesan,
J. J. Skehel, and D. C. Wiley.
1997.
Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography.
Virology
232:19-31[CrossRef][Medline].
|
| 11.
|
Felsenstein, J.
1989.
PHYLIP phylogeny inference package (version 3.2).
Cladistics
5:164-166.
|
| 12.
|
Gambaryan, A. S., and M. N. Matrosovich.
1992.
A solid-phase enzyme-linked assay for influenza virus receptor-binding activity.
J. Virol. Methods
39:111-123[CrossRef][Medline].
|
| 13.
|
Gambaryan, A. S.,
A. B. Tuzikov,
V. E. Piskarev,
S. S. Yamnikova,
D. K. Lvov,
J. S. Robertson,
N. V. Bovin, and M. N. Matrosovich.
1997.
Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl(N-acetyllactosamine).
Virology
232:345-350[CrossRef][Medline].
|
| 14.
|
Gambaryan, A. S.,
M. N. Matrosovich,
C. A. Bender, and E. D. Kilbourne.
1998.
Differences in the biological phenotype of low-yielding (L) and high-yielding (H) variants of swine influenza virus A/NJ/11/76 are associated with their different receptor-binding activity.
Virology
247:223-231[CrossRef][Medline].
|
| 15.
|
Gambaryan, A. S.,
J. S. Robertson, and M. N. Matrosovich.
1999.
Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses.
Virology
258:232-239[CrossRef][Medline].
|
| 16.
|
Kida, H.,
Y. Kawaoka,
C. W. Naeve, and R. G. Webster.
1987.
Antigenic and genetic conservation of H3 influenza virus in wild ducks.
Virology
159:109-119[CrossRef][Medline].
|
| 17.
|
Klimov, A. I.,
C. A. Bender,
H. E. Hall, and N. J. Cox.
1996.
Evolution of human influenza A (H2N2) viruses, p. 546-552.
In
L. E. Brown, A. W. Hampson, and R. G. Webster (ed.), Options for the control of influenza III. Elsevier Science B.V., Amsterdam, The Netherlands.
|
| 18.
|
Ludwig, S.,
L. Stitz,
O. Planz,
H. Van,
W. M. Fitch, and C. Scholtissek.
1995.
European swine virus as a possible source for the next influenza pandemic?
Virology
212:555-561[CrossRef][Medline].
|
| 19.
|
Martin, J.,
S. A. Wharton,
Y. P. Lin,
D. K. Takemoto,
J. J. Skehel,
D. C. Wiley, and D. A. Steinhauer.
1998.
Studies of the binding properties of influenza hemagglutinin receptor-site mutants.
Virology
241:101-111[CrossRef][Medline].
|
| 20.
|
Matrosovich, M.,
P. Gao, and Y. Kawaoka.
1998.
Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host.
J. Virol.
72:6373-6380[Abstract/Free Full Text].
|
| 21.
|
Matrosovich, M.,
N. Zhou,
Y. Kawaoka, and R. Webster.
1999.
The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.
J. Virol.
73:1146-1155[Abstract/Free Full Text].
|
| 22.
|
Matrosovich, M. N.,
A. S. Gambaryan,
A. B. Tuzikov,
N. E. Byramova,
L. V. Mochalova,
A. A. Golbraikh,
M. D. Shenderovich,
J. Finne, and N. V. Bovin.
1993.
Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides.
Virology
196:111-121[CrossRef][Medline].
|
| 23.
|
Matrosovich, M. N.,
A. S. Gambaryan,
S. Teneberg,
V. E. Piskarev,
S. S. Yamnikova,
D. K. Lvov,
J. S. Robertson, and K. A. Karlsson.
1997.
Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.
Virology
233:224-234[CrossRef][Medline].
|
| 24.
|
Naeve, C. W.,
V. S. Hinshaw, and R. G. Webster.
1984.
Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus.
J. Virol.
51:567-569[Abstract/Free Full Text].
|
| 25.
|
Nicholas, K. B.,
H. B. Nicholas, Jr., and D. W. Deerfield.
1997.
GeneDoc: analysis and visualization of genetic variation.
EMBNEW News
4:14-14.
|
| 26.
|
Nobusawa, E.,
T. Aoyama,
H. Kato,
Y. Suzuki,
Y. Tateno, and K. Nakajima.
1991.
Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses.
Virology
182:475-485[CrossRef][Medline].
|
| 27.
|
Page, R. D. M.
1996.
TREEVIEW: an application to display phylogenetic trees on personal computers.
Comput. Appl. Biosci.
12:357-358[Free Full Text].
|
| 28.
|
Paulson, J. C.
1985.
Interactions of animal viruses with cell surface receptors, p. 131-219.
In
M. Conn (ed.), The receptors, vol. 2. Academic Press, Inc., Orlando, Fla.
|
| 29.
|
Raymond, F. L.,
A. J. Caton,
N. J. Cox,
A. P. Kendal, and G. G. Brownlee.
1986.
The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene.
Virology
148:275-287[CrossRef][Medline].
|
| 30.
|
Reid, A. H.,
T. G. Fanning,
J. V. Hultin, and J. K. Taubenberger.
1999.
Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene.
Proc. Natl. Acad. Sci. USA
96:1651-1656[Abstract/Free Full Text].
|
| 30a.
|
Robertson, J. S.
1993.
Clinical influenza virus and the embryonated hen's eggs.
Rev. Med. Virol.
3:97-106.
|
| 31.
|
Rogers, G. N.,
J. C. Paulson,
R. S. Daniels,
J. J. Skehel,
I. A. Wilson, and D. C. Wiley.
1983.
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity.
Nature
304:76-78[CrossRef][Medline].
|
| 32.
|
Rogers, G. N.,
T. J. Pritchett,
J. L. Lane, and J. C. Paulson.
1983.
Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants.
Virology
131:394-408[CrossRef][Medline].
|
| 33.
|
Rogers, G. N., and B. L. D'Souza.
1989.
Receptor binding properties of human and animal H1 influenza virus isolates.
Virology
173:317-322[CrossRef][Medline].
|
| 34.
|
Sayle, R., and E. J. Milner-White.
1995.
RasMol: biomolecular graphics for all.
Trends Biochem. Sci.
20:374[CrossRef][Medline].
|
| 35.
|
Schafer, J. R.,
Y. Kawaoka,
W. J. Bean,
J. Suss,
D. Senne, and R. G. Webster.
1993.
Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir.
Virology
194:781-788[CrossRef][Medline].
|
| 36.
|
Scholtissek, C.,
H. Burger,
P. A. Bachmann, and C. Hannoun.
1983.
Genetic relatedness of hemagglutinins of the H1 subtype of influenza A viruses isolated from swine and birds.
Virology
129:521-523[CrossRef][Medline].
|
| 37.
|
Subbarao, K.,
A. Klimov,
J. Katz,
H. Regnery,
W. Lim,
H. Hall,
M. Perdue,
D. Swayne,
C. Bender,
J. Huang,
M. Hemphill,
T. Rowe,
M. Shaw,
X. Y. Xu,
K. Fukuda, and N. Cox.
1998.
Characterization of an avian influenza (H5N1) virus isolated from a child with a fatal respiratory illness.
Science
279:393-396[Abstract/Free Full Text].
|
| 38.
|
Suzuki, T.,
G. Horiike,
Y. Yamazaki,
K. Kawabe,
H. Masuda,
D. Miyamoto,
M. Matsuda,
S. I. Nishimura,
T. Yamagata,
T. Ito,
H. Kida,
Y. Kawaoka, and Y. Suzuki.
1997.
Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium.
FEBS Lett.
404:192-196[CrossRef][Medline].
|
| 39.
|
Vines, A.,
K. Wells,
M. Matrosovich,
M. R. Castrucci,
T. Ito, and Y. Kawaoka.
1998.
The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction.
J. Virol.
72:7626-7631[Abstract/Free Full Text].
|
| 40.
|
Webster, R. G.,
W. J. Bean,
O. T. Gorman,
T. M. Chambers, and Y. Kawaoka.
1992.
Evolution and ecology of influenza A viruses.
Microbiol. Rev.
56:152-179[Abstract/Free Full Text].
|
| 41.
|
Xu, X.,
E. P. Rocha,
H. L. Regenery,
A. P. Kendal, and N. J. Cox.
1993.
Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986-1991.
Virus Res.
28:37-55[CrossRef][Medline].
|
Journal of Virology, September 2000, p. 8502-8512, Vol. 74, No. 18
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Liu, J., Stevens, D. J., Haire, L. F., Walker, P. A., Coombs, P. J., Russell, R. J., Gamblin, S. J., Skehel, J. J.
(2009). From the Cover: Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957. Proc. Natl. Acad. Sci. USA
106: 17175-17180
[Abstract]
[Full Text]
-
Sorrell, E. M., Wan, H., Araya, Y., Song, H., Perez, D. R.
(2009). Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc. Natl. Acad. Sci. USA
106: 7565-7570
[Abstract]
[Full Text]
-
Weingartl, H. M., Albrecht, R. A., Lager, K. M., Babiuk, S., Marszal, P., Neufeld, J., Embury-Hyatt, C., Lekcharoensuk, P., Tumpey, T. M., Garcia-Sastre, A., Richt, J. A.
(2009). Experimental Infection of Pigs with the Human 1918 Pandemic Influenza Virus. J. Virol.
83: 4287-4296
[Abstract]
[Full Text]
-
Qi, L., Kash, J. C., Dugan, V. G., Wang, R., Jin, G., Cunningham, R. E., Taubenberger, J. K.
(2009). Role of Sialic Acid Binding Specificity of the 1918 Influenza Virus Hemagglutinin Protein in Virulence and Pathogenesis for Mice. J. Virol.
83: 3754-3761
[Abstract]
[Full Text]
-
Van Hoeven, N., Pappas, C., Belser, J. A., Maines, T. R., Zeng, H., Garcia-Sastre, A., Sasisekharan, R., Katz, J. M., Tumpey, T. M.
(2009). Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc. Natl. Acad. Sci. USA
106: 3366-3371
[Abstract]
[Full Text]
-
Suzuki, Y., Taira, K., Saito, R., Nidaira, M., Okano, S., Zaraket, H., Suzuki, H.
(2009). Epidemiologic Study of Influenza Infection in Okinawa, Japan, from 2001 to 2007: Changing Patterns of Seasonality and Prevalence of Amantadine-Resistant Influenza A Virus. J. Clin. Microbiol.
47: 623-629
[Abstract]
[Full Text]
-
Keleta, L., Ibricevic, A., Bovin, N. V., Brody, S. L., Brown, E. G.
(2008). Experimental Evolution of Human Influenza Virus H3 Hemagglutinin in the Mouse Lung Identifies Adaptive Regions in HA1 and HA2. J. Virol.
82: 11599-11608
[Abstract]
[Full Text]
-
Bateman, A. C., Busch, M. G., Karasin, A. I., Bovin, N., Olsen, C. W.
(2008). Amino Acid 226 in the Hemagglutinin of H4N6 Influenza Virus Determines Binding Affinity for {alpha}2,6-Linked Sialic Acid and Infectivity Levels in Primary Swine and Human Respiratory Epithelial Cells. J. Virol.
82: 8204-8209
[Abstract]
[Full Text]
-
Oh, D. Y., Barr, I. G., Mosse, J. A., Laurie, K. L.
(2008). MDCK-SIAT1 Cells Show Improved Isolation Rates for Recent Human Influenza Viruses Compared to Conventional MDCK Cells. J. Clin. Microbiol.
46: 2189-2194
[Abstract]
[Full Text]
-
Belser, J. A., Blixt, O., Chen, L.-M., Pappas, C., Maines, T. R., Van Hoeven, N., Donis, R., Busch, J., McBride, R., Paulson, J. C., Katz, J. M., Tumpey, T. M.
(2008). Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility. Proc. Natl. Acad. Sci. USA
105: 7558-7563
[Abstract]
[Full Text]
-
Meisner, J., Szretter, K. J., Bradley, K. C., Langley, W. A., Li, Z.-N., Lee, B.-J., Thoennes, S., Martin, J., Skehel, J. J., Russell, R. J., Katz, J. M., Steinhauer, D. A.
(2008). Infectivity Studies of Influenza Virus Hemagglutinin Receptor Binding Site Mutants in Mice. J. Virol.
82: 5079-5083
[Abstract]
[Full Text]
-
Korteweg, C., Gu, J.
(2008). Pathology, Molecular Biology, and Pathogenesis of Avian Influenza A (H5N1) Infection in Humans. Am. J. Pathol.
172: 1155-1170
[Abstract]
[Full Text]
-
Yu, H., Hua, R.-H., Zhang, Q., Liu, T.-Q., Liu, H.-L., Li, G.-X., Tong, G.-Z.
(2008). Genetic Evolution of Swine Influenza A (H3N2) Viruses in China from 1970 to 2006. J. Clin. Microbiol.
46: 1067-1075
[Abstract]
[Full Text]
-
Ma, W., Vincent, A. L., Gramer, M. R., Brockwell, C. B., Lager, K. M., Janke, B. H., Gauger, P. C., Patnayak, D. P., Webby, R. J., Richt, J. A.
(2007). Identification of H2N3 influenza A viruses from swine in the United States. Proc. Natl. Acad. Sci. USA
104: 20949-20954
[Abstract]
[Full Text]
-
McDonald, N. J., Smith, C. B., Cox, N. J.
(2007). Antigenic drift in the evolution of H1N1 influenza A viruses resulting from deletion of a single amino acid in the haemagglutinin gene. J. Gen. Virol.
88: 3209-3213
[Abstract]
[Full Text]
-
Owen, R. E., Yamada, E., Thompson, C. I., Phillipson, L. J., Thompson, C., Taylor, E., Zambon, M., Osborn, H. M. I., Barclay, W. S., Borrow, P.
(2007). Alterations in Receptor Binding Properties of Recent Human Influenza H3N2 Viruses Are Associated with Reduced Natural Killer Cell Lysis of Infected Cells. J. Virol.
81: 11170-11178
[Abstract]
[Full Text]
-
Newby, C. M., Sabin, L., Pekosz, A.
(2007). The RNA Binding Domain of Influenza A Virus NS1 Protein Affects Secretion of Tumor Necrosis Factor Alpha, Interleukin-6, and Interferon in Primary Murine Tracheal Epithelial Cells. J. Virol.
81: 9469-9480
[Abstract]
[Full Text]
-
Cong, Y. L., Pu, J., Liu, Q. F., Wang, S., Zhang, G. Z., Zhang, X. L., Fan, W. X., Brown, E. G., Liu, J. H.
(2007). Antigenic and genetic characterization of H9N2 swine influenza viruses in China. J. Gen. Virol.
88: 2035-2041
[Abstract]
[Full Text]
-
Yen, H.-L., Lipatov, A. S., Ilyushina, N. A., Govorkova, E. A., Franks, J., Yilmaz, N., Douglas, A., Hay, A., Krauss, S., Rehg, J. E., Hoffmann, E., Webster, R. G.
(2007). Inefficient Transmission of H5N1 Influenza Viruses in a Ferret Contact Model. J. Virol.
81: 6890-6898
[Abstract]
[Full Text]
-
Hayman, A., Comely, S., Lackenby, A., Hartgroves, L. C. S., Goodbourn, S., McCauley, J. W., Barclay, W. S.
(2007). NS1 Proteins of Avian Influenza A Viruses Can Act as Antagonists of the Human Alpha/Beta Interferon Response. J. Virol.
81: 2318-2327
[Abstract]
[Full Text]
-
Tumpey, T. M., Maines, T. R., Van Hoeven, N., Glaser, L., Solorzano, A., Pappas, C., Cox, N. J., Swayne, D. E., Palese, P., Katz, J. M., Garcia-Sastre, A.
(2007). A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission. Science
315: 655-659
[Abstract]
[Full Text]
-
Weber, S., Harder, T., Starick, E., Beer, M., Werner, O., Hoffmann, B., Mettenleiter, T. C., Mundt, E.
(2007). Molecular analysis of highly pathogenic avian influenza virus of subtype H5N1 isolated from wild birds and mammals in northern Germany. J. Gen. Virol.
88: 554-558
[Abstract]
[Full Text]
-
Nam, H.-J., Gurda-Whitaker, B., Gan, W. Y., Ilaria, S., McKenna, R., Mehta, P., Alvarez, R. A., Agbandje-McKenna, M.
(2006). Identification of the Sialic Acid Structures Recognized by Minute Virus of Mice and the Role of Binding Affinity in Virulence Adaptation. J. Biol. Chem.
281: 25670-25677
[Abstract]
[Full Text]
-
Maines, T. R., Chen, L.-M., Matsuoka, Y., Chen, H., Rowe, T., Ortin, J., Falcon, A., Hien, N. T., Mai, L. Q., Sedyaningsih, E. R., Harun, S., Tumpey, T. M., Donis, R. O., Cox, N. J., Subbarao, K., Katz, J. M.
(2006). Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc. Natl. Acad. Sci. USA
103: 12121-12126
[Abstract]
[Full Text]
-
Ibricevic, A., Pekosz, A., Walter, M. J., Newby, C., Battaile, J. T., Brown, E. G., Holtzman, M. J., Brody, S. L.
(2006). Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells.. J. Virol.
80: 7469-7480
[Abstract]
[Full Text]
-
Thompson, C. I., Barclay, W. S., Zambon, M. C., Pickles, R. J.
(2006). Infection of human airway epithelium by human and avian strains of influenza a virus.. J. Virol.
80: 8060-8068
[Abstract]
[Full Text]
-
Stevens, J., Blixt, O., Tumpey, T. M., Taubenberger, J. K., Paulson, J. C., Wilson, I. A.
(2006). Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus. Science
312: 404-410
[Abstract]
[Full Text]
-
Karasin, A. I., Carman, S., Olsen, C. W.
(2006). Identification of Human H1N2 and Human-Swine Reassortant H1N2 and H1N1 Influenza A Viruses among Pigs in Ontario, Canada (2003 to 2005).. J. Clin. Microbiol.
44: 1123-1126
[Abstract]
[Full Text]
-
Lopez-Bueno, A., Rubio, M.-P., Bryant, N., McKenna, R., Agbandje-McKenna, M., Almendral, J. M.
(2006). Host-Selected Amino Acid Changes at the Sialic Acid Binding Pocket of the Parvovirus Capsid Modulate Cell Binding Affinity and Determine Virulence. J. Virol.
80: 1563-1573
[Abstract]
[Full Text]
-
Crawford, P. C., Dubovi, E. J., Castleman, W. L., Stephenson, I., Gibbs, E. P. J., Chen, L., Smith, C., Hill, R. C., Ferro, P., Pompey, J., Bright, R. A., Medina, M.-J., Influenza Genomics Group, , Johnson, C. M., Olsen, C. W., Cox, N. J., Klimov, A. I., Katz, J. M., Donis, R. O.
(2005). Transmission of Equine Influenza Virus to Dogs. Science
310: 482-485
[Abstract]
[Full Text]
-
Mishin, V. P., Novikov, D., Hayden, F. G., Gubareva, L. V.
(2005). Effect of Hemagglutinin Glycosylation on Influenza Virus Susceptibility to Neuraminidase Inhibitors. J. Virol.
79: 12416-12424
[Abstract]
[Full Text]
-
Glaser, L., Stevens, J., Zamarin, D., Wilson, I. A., Garcia-Sastre, A., Tumpey, T. M., Basler, C. F., Taubenberger, J. K., Palese, P.
(2005). A Single Amino Acid Substitution in 1918 Influenza Virus Hemagglutinin Changes Receptor Binding Specificity. J. Virol.
79: 11533-11536
[Abstract]
[Full Text]
-
Shinya, K., Hatta, M., Yamada, S., Takada, A., Watanabe, S., Halfmann, P., Horimoto, T., Neumann, G., Kim, J. H., Lim, W., Guan, Y., Peiris, M., Kiso, M., Suzuki, T., Suzuki, Y., Kawaoka, Y.
(2005). Characterization of a Human H5N1 Influenza A Virus Isolated in 2003. J. Virol.
79: 9926-9932
[Abstract]
[Full Text]
-
Lee, C.-W., Suarez, D. L., Tumpey, T. M., Sung, H.-W., Kwon, Y.-K., Lee, Y.-J., Choi, J.-G., Joh, S.-J., Kim, M.-C., Lee, E.-K., Park, J.-M., Lu, X., Katz, J. M., Spackman, E., Swayne, D. E., Kim, J.-H.
(2005). Characterization of Highly Pathogenic H5N1 Avian Influenza A Viruses Isolated from South Korea. J. Virol.
79: 3692-3702
[Abstract]
[Full Text]
-
Karasin, A. I., West, K., Carman, S., Olsen, C. W.
(2004). Characterization of Avian H3N3 and H1N1 Influenza A Viruses Isolated from Pigs in Canada. J. Clin. Microbiol.
42: 4349-4354
[Abstract]
[Full Text]
-
Thompson, C. I., Barclay, W. S., Zambon, M. C.
(2004). Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. J Antimicrob Chemother
53: 759-765
[Abstract]
[Full Text]
-
Iwatsuki-Horimoto, K., Kanazawa, R., Sugii, S., Kawaoka, Y., Horimoto, T.
(2004). The index influenza A virus subtype H5N1 isolated from a human in 1997 differs in its receptor-binding properties from a virulent avian influenza virus. J. Gen. Virol.
85: 1001-1005
[Abstract]
[Full Text]
-
Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A., Klenk, H.-D.
(2004). Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA
101: 4620-4624
[Abstract]
[Full Text]
-
Gamblin, S. J., Haire, L. F., Russell, R. J., Stevens, D. J., Xiao, B., Ha, Y., Vasisht, N., Steinhauer, D. A., Daniels, R. S., Elliot, A., Wiley, D. C., Skehel, J. J.
(2004). The Structure and Receptor Binding Properties of the 1918 Influenza Hemagglutinin. Science
303: 1838-1842
[Abstract]
[Full Text]
-
Harvey, R., Martin, A. C. R., Zambon, M., Barclay, W. S.
(2004). Restrictions to the Adaptation of Influenza A Virus H5 Hemagglutinin to the Human Host. J. Virol.
78: 502-507
[Abstract]
[Full Text]
-
Matrosovich, M., Matrosovich, T., Carr, J., Roberts, N. A., Klenk, H.-D.
(2003). Overexpression of the {alpha}-2,6-Sialyltransferase in MDCK Cells Increases Influenza Virus Sensitivity to Neuraminidase Inhibitors. J. Virol.
77: 8418-8425
[Abstract]
[Full Text]
-
Kobasa, D., Wells, K., Kawaoka, Y.
(2001). Amino Acids Responsible for the Absolute Sialidase Activity of the Influenza A Virus Neuraminidase: Relationship to Growth in the Duck Intestine. J. Virol.
75: 11773-11780
[Abstract]
[Full Text]
-
Ha, Y., Stevens, D. J., Skehel, J. J., Wiley, D. C.
(2001). X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc. Natl. Acad. Sci. USA
10.1073/pnas.201401198v1
[Abstract]
[Full Text]
-
Ha, Y., Stevens, D. J., Skehel, J. J., Wiley, D. C.
(2001). X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc. Natl. Acad. Sci. USA
98: 11181-11186
[Abstract]
[Full Text]